Native CT-II
AssetAlso undenatured type II collagen
Undenatured type II collagen promoting joint health and immune tolerance
- Stage
- Human trials
- Modality
- Supplement
- Target
- Inflammation
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Knee osteoarthritis
Human trials, Completed, NCT06917287, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1
- Evidence for its targets1
- Competitors4
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026, 1 source